Serum YKL-40 reflects pharmacological induced reduction of synovial inflammation of the knee joint in patients with rheumatoid arthritis

被引：0
|
作者：
Volck, B
Johansen, JS
Stoltenberg, M
Ostergaard, M
Price, PA
Lorenzen, I
机构：
[1] UNIV COPENHAGEN,HVIDOVRE HOSP,DEPT RHEUMATOL,COPENHAGEN,DENMARK
[2] UNIV CALIF SAN DIEGO,DEPT BIOL,SAN DIEGO,CA 92103
来源：
ARTHRITIS AND RHEUMATISM | 1996年 / 39卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：769 / 769
页数：1
相关论文
共 50 条
  • [21] Serum YKL-40 levels in rheumatoid arthritis: Correlations between clinical and laborarory parameters
    Matsumoto, T
    Tsurumoto, T
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (06) : 655 - 660
  • [22] A NEW BIOCHEMICAL MARKER FOR JOINT INJURY - ANALYSIS OF YKL-40 IN SERUM AND SYNOVIAL-FLUID
    JOHANSEN, JS
    JENSEN, HS
    PRICE, PA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (11): : 949 - 955
  • [23] Elevated Serum Levels of YKL-40, YKL-39, and SI-CLP in Patients with Treatment Failure to DMARDs in Patients with Rheumatoid Arthritis
    Esparza-Diaz, Jose David Tadeo
    Gamez-Nava, Jorge Ivan
    Gonzalez-Lopez, Laura
    Saldana-Cruz, Ana Miriam
    Machado-Sulbaran, Andrea Carolina
    Beltran-Ramirez, Alberto
    Guillen-Medina, Miryam Rosario
    Flores-Vargas, Ana Gabriela
    Perez-Guerrero, Edsaul Emilio
    BIOMEDICINES, 2024, 12 (07)
  • [24] Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy
    Hu, Wenlu
    Ding, Yanxia
    Guan, Kelei
    Zhang, Panpan
    Su, Jingbo
    Zhang, Chunyi
    Li, Wei
    Lian, Chaofeng
    Yang, Qihua
    Liu, Shengyun
    Li, Tianfang
    CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 1845 - 1853
  • [25] Serum YKL-40, a chondrocyte protein, is reduced by infliximab (anti-TNF) therapy in patients with rheumatoid arthritis
    Charles, PJ
    Maini, RN
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S236 - S236
  • [26] Increased Synovial Fluid YKL-40 Levels are Linked with Symptomatic Severity in Knee Osteoarthritis Patients
    Guan, Jian
    Zhang, Liu
    Li, Feng
    Feng, Jian-shu
    Wang, Hua-jun
    Chu, Jian-guo
    Song, Yong-zhou
    Xie, Lei
    Ding, Luo-bin
    CLINICAL LABORATORY, 2015, 61 (08) : 991 - 997
  • [27] Measurement of serum YKL-40 in patients with inflammatory bowel and joint diseases.
    Plebani, M
    Meneghetti, MF
    Bernardi, D
    Ujka, F
    Mussap, M
    Zaninotto, M
    Punzi, L
    CLINICAL CHEMISTRY, 2000, 46 (06) : A173 - A173
  • [28] DOES SERUM YKL-40 REFLECT DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS
    JOHANSEN, JS
    HANSEN, M
    STOLTENBERG, M
    HVOLRIS, J
    FLORESCU, A
    PRICE, PA
    HORSLEVPETERSEN, K
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 385 - 385
  • [29] Chemokine blockade in patients with rheumatoid arthritis: reduction of synovial inflammation
    Haringman, J. J.
    Kraan, M. C.
    Smeets, T. J. M.
    Tak, P. P.
    ARTHRITIS RESEARCH & THERAPY, 2002, 4
  • [30] Chemokine blockade in patients with rheumatoid arthritis: reduction of synovial inflammation
    JJ Haringman
    MC Kraan
    TJM Smeets
    PP Tak
    Arthritis Research & Therapy, 4 (Suppl 1)
12345